|
Re: 3 ASN Kidney Conference Presentations Nov 8-9
|
5
|
Resverlogix Corp.
|
Nov 08, 2019 04:39PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
5
|
Resverlogix Corp.
|
May 11, 2017 04:00PM
|
|
Next News Release
|
5
|
Resverlogix Corp.
|
May 15, 2017 03:02PM
|
|
Re: Debenture
|
5
|
Resverlogix Corp.
|
Sep 27, 2019 01:53PM
|
|
Re: Food For Thought
|
5
|
Resverlogix Corp.
|
Oct 19, 2019 03:51PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
5
|
Resverlogix Corp.
|
Nov 02, 2020 07:32PM
|
|
Re: Isreal Deal
|
6
|
Resverlogix Corp.
|
Jan 13, 2018 12:36AM
|
|
Re: Todays presentation - Archman and paladin
|
6
|
Resverlogix Corp.
|
May 12, 2021 02:59PM
|
|
Re: The jaded group of posters
|
6
|
Resverlogix Corp.
|
Nov 01, 2021 01:10PM
|
|
Re: Hopefully a late day pop?
|
6
|
Resverlogix Corp.
|
Apr 12, 2018 11:09PM
|
|
Re: Presentation
|
6
|
Resverlogix Corp.
|
Jun 20, 2017 03:16AM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Aug 29, 2018 12:53AM
|
|
Re: holy jumping cheese curds, what a jump to $3.75
|
6
|
Resverlogix Corp.
|
Sep 05, 2018 01:09PM
|
|
Re: Right of first refusal
|
6
|
Resverlogix Corp.
|
Mar 02, 2019 02:59PM
|
|
Re: Debt and 28 August
|
6
|
Resverlogix Corp.
|
Jul 28, 2017 10:04AM
|
|
Re: Will Hepalink make a move for RVX?
|
6
|
Resverlogix Corp.
|
Jul 15, 2020 12:43AM
|
|
Re: BET inhibitors and Pulmonary Hypertension
|
6
|
Resverlogix Corp.
|
Aug 01, 2018 01:15PM
|
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
6
|
Resverlogix Corp.
|
Sep 19, 2018 02:23AM
|
|
Points to ponder
|
6
|
Resverlogix Corp.
|
Jun 12, 2017 02:26AM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
6
|
Zenith Epigenetics
|
Aug 17, 2017 02:41AM
|
